Ignite Creation Date:
2025-12-24 @ 7:19 PM
Ignite Modification Date:
2026-04-18 @ 8:18 PM
Study NCT ID:
NCT01217203
Status:
COMPLETED
Last Update Posted:
2014-02-28
First Post:
2010-10-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study on the Safety, Anti-tumor Activity and Pharmacology of IPH2101 Combined With Lenalidomide in Patients With Multiple Myeloma Experiencing a First or Second Relapse
Sponsor:
Innate Pharma
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
IPH2101-202
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None